{
  "docId": "019de075-3630-758c-9196-25f7a74eb952",
  "docSlug": "7e832f58890c6d5f3f05fff919c18d79",
  "documentTitle": "Sarissa Capital | Activist Presentation Deck | 41 slides",
  "authorId": "sarissa-capital",
  "authorName": "Sarissa Capital",
  "documentKindSlug": "activist-deck",
  "documentKindLabel": "Activist deck",
  "sourceTypeSlug": "activist_investor",
  "sourceTypeLabel": "Activist investor",
  "presentationDate": "2023-06-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 41,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 4,
  "notes": "Uses a side-by-side bar chart comparison to highlight the inefficiency of revenue growth relative to cost growth.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-3630-758c-9196-25f7a74eb952/6",
  "deckHref": "/decks/019de075-3630-758c-9196-25f7a74eb952",
  "deckJsonHref": "/decks/019de075-3630-758c-9196-25f7a74eb952.json",
  "deckAnchorHref": "/decks/019de075-3630-758c-9196-25f7a74eb952#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.84,
        "x": 0.08,
        "y": 0.75
      },
      "kind": "callout",
      "text": "Commercial business is inefficient and does not maximize shareholder value",
      "attrs": null,
      "subkind": "primary",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2345d322-1f89-42a1-b3b4-d92c61a1eca1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.12,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Alkermes Commercial Revenues",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a0c6739-f46e-41d5-bc38-016b15a03290",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.38,
        "x": 0.52,
        "y": 0.25
      },
      "kind": "chart",
      "text": "Alkermes GAAP SG&A",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f979c195-9202-4f56-a484-7626bcf66843",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.02,
        "y": 0.88
      },
      "kind": "disclaimer",
      "text": "Sources: Alkermes press releases. Commercial Revenues include Vivitrol, Aristada and Lybalvi",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "634a7471-fc2d-460e-9551-399ab2df8341",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.85,
        "x": 0.07,
        "y": 0.08
      },
      "kind": "title",
      "text": "Even 2023 commercial revenue growth comes at a steep cost and barely overcomes SG&A growth",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d22ab699-8b60-4644-8577-a54c12225fa8",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "fraud-exposure",
      "slug": null,
      "matchId": "dbfbac3e-14d4-4400-a26a-d1a4342a10db",
      "evidence": "The slide explicitly frames the company's financial performance as inefficient to challenge management.",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 18,
      "from": 3,
      "beatId": "2e54f238-7c27-4c8c-8ab6-89c530a472a9",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "The Monster",
      "beatSlug": "overcoming-monster-the-monster",
      "evidence": "Slides 3-18 present the problem and the villain, highlighting Alkermes' poor performance and lack of accountability",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Hook",
      "parentBeatSlug": "hook"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "451fc63b-ae88-4091-bd35-fe6ee701b9c8",
      "evidence": "The document highlights the poor performance of Alkermes and the need for change",
      "position": 0,
      "objective": "What is the cost of inaction for Alkermes' shareholders?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}